Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedixTSE:331A -0.41%20 Return-on-Tangible-Asset is 7.02% as of Mar. 2026, which is 44% below its 10-year median of 12.52. GuruFocus rates TSE:331A with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 1,030 Media - Diversified companies, Medix ranks better than 73.5% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Medix's annualizedNet Income for the quarter that ended in Mar. 2026 was 円507 Mil. Medix's average total tangible assets for the quarter that ended in Mar. 2026 was 円7,212 Mil. Therefore, Medix's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 7.02%.
The historical rank and industry rank for Medix's Return-on-Tangible-Asset or its related term are showing as below:
TSE:331A'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 5.61 Med: 12.52 Max: 19.29
Current: 5.61
During the past 4 years, Medix's highest Return-on-Tangible-Asset was 19.29%. The lowest was 5.61%. And the median was 12.52%.
TSE:331A's Return-on-Tangible-Asset is ranked better than 73.5% of 1030
companies
in the Media - Diversified industry
Industry Median: 0.785
vs TSE:331A: 5.61
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Medix Return-on-Tangible-Asset Related Terms
Medix Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Medix's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:331A vs APP, OMC, TTD: Return-on-Tangible-Asset Comparison
For the Advertising Agencies subindustry, Medix's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medix Return-on-Tangible-Asset vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Medix's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Medix's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 7.02% mean?
Medix (TSE:331A) has a Return-on-Tangible-Asset of 7.02% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Medix and its competitors. This is 44% below median its historical median of 12.52. Over the past decade, Medix's Return-on-Tangible-Asset has ranged from 5.61 to 19.29. According to the industry distribution chart, Medix ranks #273 out of 1030 companies in the Media - Diversified industry, placing it in the top 26.5%.
Is Medix's Return-on-Tangible-Asset too high?
Medix's current Return-on-Tangible-Asset of 7.02% is 44% below median its 10-year median of 12.52. Over the past 10 years, this metric has ranged from a low of 5.61 to a high of 19.29. The Media - Diversified industry median Return-on-Tangible-Asset is 0.79. Medix's value of 7.02% is 794.3% above this industry median. Based on the distribution chart, Medix ranks #273 out of 1030 companies in the Media - Diversified industry, which is above the industry midpoint. Overall, Medix has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Medix's Return-on-Tangible-Asset compare to APP and OMC?
According to the Media - Diversified industry distribution chart, Medix ranks #273 out of 1030 companies for Return-on-Tangible-Asset. This puts Medix in the upper half of its industry. The industry median Return-on-Tangible-Asset is 0.79. Medix's value of 7.02% is 794.3% above this benchmark. Historically, Medix's own Return-on-Tangible-Asset has ranged from 5.61 to 19.29 over the past decade. While the company's 10-year median is 12.52 vs. the industry median of 0.79, Medix has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Media - Diversified company?
The median Return-on-Tangible-Asset among Media - Diversified companies is 0.79, based on 1,030 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medix's current Return-on-Tangible-Asset of 7.02% is 794.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Medix and its competitors. For the Media - Diversified industry, the median Return-on-Tangible-Asset is 0.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medix's current Return-on-Tangible-Asset is 7.02%, which is 44% below median its own 10-year median of 12.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medix stock overvalued right now?
Medix (TSE:331A) has a current Return-on-Tangible-Asset of 7.02%. The current Return-on-Tangible-Asset is 7.02%, which is 44% below median its 10-year median of 12.52 and 794.3% above the Media - Diversified industry median of 0.79. Medix's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Medix (TSE:331A), the current Return-on-Tangible-Asset is 7.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medix Inc is an internet advertising agency that places the utmost importance on understanding its clients' business models deeply and helping them solve problems over the medium to long term. It is engaged in Digital marketing services including creative design and production, data parsing and analysis, and Internet advertising services. The company provides services in the digital marketing field to clients in various lines and industries.
20GF Score
Get the complete analysis for TSE:331A
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:331A has been successfully added to your 
